Immunomodulation by heavy metals as a contributing factor to inflammatory diseases and autoimmune reactions: Cadmium as an example

Immunol Lett. 2021 Dec:240:106-122. doi: 10.1016/j.imlet.2021.10.003. Epub 2021 Oct 21.

Abstract

Cadmium (Cd) represents a unique hazard because of the long biological half-life in humans (20-30 years). This metal accumulates in organs causing a continuum of responses, with organ disease/failure as extreme outcome. Some of the cellular and molecular alterations in target tissues can be related to immune-modulating potential of Cd. This metal may cause adverse responses in which components of the immune system function as both mediators and effectors of Cd tissue toxicity, which, in combination with Cd-induced alterations in homeostatic reparative activities may contribute to tissue dysfunction. In this work, current knowledge concerning inflammatory/autoimmune disease manifestations found to be related with cadmium exposure are summarized. Along with epidemiological evidence, animal and in vitro data are presented, with focus on cellular and molecular immune mechanisms potentially relevant for the disease susceptibility, disease promotion, or facilitating development of pre-existing pathologies.

Keywords: Cadmium; Disease promotion; Health effects; Inflammatory/autoimmune reactions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases* / chemically induced
  • Autoimmune Diseases* / immunology
  • Cadmium / toxicity*
  • Humans
  • Immunomodulation*
  • Inflammation / chemically induced
  • Inflammation / immunology

Substances

  • Cadmium